Ernst & Young

News

The biotech industry in the US is facing a period of deep uncertainty under the Trump administration, but can ride out the storm, says EY.

Digital

Underinvestment in medical technology could threaten growth in the sector, according to a report by Ernst & Young (EY).

Oncology

Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Ernst &amp; Young